The effect of long-term growth hormone (GH) treatment on bone mineral density in children with GH deficiency. Role of GH in the attainment of peak bone mass

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 8, 1996, Pages 3077-3083

  Saggese, Giuseppe ^a   Baroncelli, Giampiero Igli ^a   Bertelloni, Silvano ^a   Barsanti, Stefania ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE;

ADOLESCENT; ARTICLE; BONE MASS; BONE MATURATION; BONE MINERAL; CLINICAL ARTICLE; FEMALE; FRACTURE TREATMENT; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; MAINTENANCE THERAPY; MALE; OSTEOPOROSIS; PHOTON ABSORPTIOMETRY; PRIORITY JOURNAL; SCHOOL CHILD; SHORT STATURE;

ADOLESCENT; BODY HEIGHT; BODY MASS INDEX; BONE DENSITY; BONE DEVELOPMENT; CHILD; FEMALE; GROWTH DISORDERS; GROWTH HORMONE; HUMANS; MALE; RECOMBINANT PROTEINS; TIME FACTORS;

EID: 0029841113     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.8.3077     Document Type: Article

References (30)

1. Shore RM, Chesney RW, Mazess RB, Rose PG, Bargman GJ. 1980 Bone mineral status in growth hormone deficiency. J Pediatr. 96:393 - 396.
2. Zamboni G, Antoniazzi F, Radetti G, Musumeci C, Tatò L. 1991 Effect of two different regimens of recombinant human growth hormone therapy on the bone mineral density of patients with growth hormone deficiency. J Pediatr. 119:483 - 485.
3. Saggese G, Baroncelli GI, Bertelloni S, Cinquanta L, Di Nero G. 1993 Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency. J Pediatr. 122:37 - 45.
4. Kaufman J-M, Taelman P, Vermeulen A, Vandeweghe M. 1992 Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset. J Clin Endocrinol Metab. 74:118 - 123.
5. Hyer SL, Rodin DA, Tobias JH, Leiper A, Nussey SS. 1992 Growth hormone deficiency during puberty reduces adult bone mineral density. Arch Dis Child. 67:1472 - 1474.
6. O'Halloran DJ, Tsatsoulis A, Whitehouse RW, Holmes SJ, Adams JE, Shalet SM. 1993 Increased bone density after recombinant human growth hormone (GH) therapy in adults with isolated GH deficiency. J Clin Endocrinol Metab. 76:1344 - 1348.
7. De Boer H, Blok GJ, Van Lingen A, Teule GJJ, Lips P, Van Der Veen EA. 1944 Consequences of childhood-onset growth hormone deficiency for adult bone mass. J Bone Miner Res. 9:1319 - 1326.
8. Johansson AG, Burman P, Westermark K, Ljunghall S. 1992 The bone mineral density in acquired growth hormone deficiency correlates with circulating levels of insulin-like growth factor I. J Intern Med. 232:447 - 452.
9. Rosen T, Hansson T, Granhed H, Szucs J, Bengtsson B-A. 1993 Reduced bone mineral content in adult patients with growth hormone deficiency. Acta Endocrinol (Copenh). 129:201 - 206.
10. Holmes SJ, Economou G, Whitehouse RW, Adams JE, Shalet SM. 1994 Reduced bone mineral density in patients with adult onset growth hormone deficiency. J Clin Endocrinol Metab. 78.669 - 674.
11. Degerblad M, Elgindy N, Hall K, Sjoberg HE, Thoren M. 1992 Potent effect of recombinant growth hormone on bone mineral density and body composition in adults with panhypopituitarism. Acta Endocrinol (Copenh). 126:387 - 393.
12. Vandeweghe M, Taelman P, Kaufman JM. 1993 Short- and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone-deficient males. Clin Endocrinol (Oxf). 39:409 - 415.
13. Matkovic V, Jelic T, Wardlaw GM, et al. 1994 Timing of peak bone mass in caucasian females and its implication for the prevention ot osteoporosis. Inference from a cross-sectional model. J Clin Invest. 93:799 - 808.
14. Bonjour J-PH, Theintz G, Buchs B, Slosman D, Rizzoli R. 1991 Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence. J Clin Endocrinol Metab. 73:555 - 563.
15. Theintz G, Buchs B, Rizzoli R, et al. 1992 Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and fermoral neck in female subjects. J Clin Endocrinol Metab. 75:1060 - 1065.
16. Wuster C, Slenczka E, Ziegler R. 1991 Increased prevalence of osteoporosis and arteriosclerosis in conventionally substituted anterior pituitary insufficiency: need for additional growth hormone substitution? Klin Wochenschr. 69:769 - 773.
17. Rosen T, Wilhelmsen L, Landin-Wilhelmsen K, Lappas G, Lindstedt G, Bengtsson B-A. Increased fracture rate in growth hormone deficient adults. Program of the 77th Annual Meeting of The Endocrine Society, Washington DC, 1995, p 353.
18. Saggese G, Cesaretti G. 1989 Criteria for recognition of the growth-inefficient child who may respond to treatment with growth hormone. Am J Dis Child. 143:1287 - 1293.
19. Saggese G, Federico G, Ghirri P, Cipriani J, Bertelloni S, Baroncelli GI. 1986 Bone mineral content in pediatrics: normal values between 2 and 19 years. First Italian data. Minerva Pediatr. 38:545 - 551.
20. Del Rio L, Carrascosa A, Pons F, Gusinyè M, Yeste D, Domenech FM. 1994 Bone mineral density of the lumbar spine in white mediterranean spanish children and adolescents: changes related to age, sex, and puberty. Pediatr Res. 35:362 - 366.
21. Tanner JM, Whitehouse RH, Takaishi M. 1966 Standards from birth to maturity for height, weight, height velocity and weight velocity: British children - 1965. Arch Dis Child. 41:454 - 471, 613 - 634.
22. Ranke MB. 1995 Growth hormone therapy in children: when to stop? Horm Res. 43:122 - 125.
23. Greulich WW, Pyle SI. 1959 Radiographic atlas of skeletal development of the hand and wrist. 2nd ed. Stanford, California: Stanford University Press.
24. Kroger H, Kotaniemi A, Vainio P, Alhava E. 1992 Bone densitometry of the spine and femur in children by dual-energy x-ray absorptiometry. Bone Miner. 17:75 - 85.
25. Saggese G, Baroncelli GI, Bertelloni S, Cinquanta L, Di Nero G. 1994 Twentyfour-hour osteocalcin, carboxyterminal propeptide of type I procollagen, and amino-terminal propeptide of type III procollagen rhythms in normal and growth-retarded children. Pediatr Res. 35:409 - 415.
26. Carey DE, Goldberg B, Ratzan SK, Rubin KR, Rowe DW. 1984 Radioimmunoassay for type 1 procollagen in growth hormone-deficient children before and during treatment with growth hormone. Pediatr Res. 19:8 - 11.
27. Dempster DW, Anderson JJ. 1990 Pathogenesis of osteoporosis. Lancet. 341: 797 - 801.
28. Holmes SJ, Whitehouse RW, Economou G, O'Halloran DJ, Adams JE, Shalet SM. 1995 Further increase in forearm cortical bone mineral content after discontinuation of growth hormone replacement. Clin Endocrinol (Oxf). 42:3 - 7.
29. Melton LJ, Atkinson EJ, O'Fallon WM, Wahner HW, Riggs BL. 1993 Longterm fracture prediction by bone mineral assessed at different skeletal sites. J Bone Miner Res. 8:1227 - 1233.
30. Schonau E, Schiedermaier U, Mokow E, et al. 1996 Development of muscle and bone strength during childhood and adolescence. In: Schonau E, ed. New-trends and diagnostic possibilities in paediatric osteology. Amsterdam: Elsevier Scientific; 147 - 158.